Nonprofit hospitals expand longevity clinics despite limited RCT evidence for $5,500 assessment packages

The STAT investigation describes treadmill-based VO2 max testing and cognitive scans at Northwestern-affiliated clinics, marketed as precise aging trajectory maps. These assessments build on observational data linking higher cardiorespiratory fitness to lower all-cause mortality, yet the clinics provide no control-group outcomes or cost-effectiveness analyses. Nonprofit status raises questions about cross-subsidization of premium services for wealthier patients while core charity obligations remain unquantified in the reporting.

Related programs at Mayo Clinic and Cleveland Clinic similarly bundle DEXA, carotid ultrasound, and epigenetic clocks without interventional trials showing net clinical benefit over standard preventive care. A 2023 JAMA Internal Medicine review of 47 biomarker panels found most lack validated thresholds for healthy aging interventions, echoing concerns that hospitals are accelerating adoption ahead of evidence. This pattern mirrors prior wellness expansions where surrogate markers drove revenue before hard endpoints were tested.

Next steps require prospective cohort studies tracking 5-year cardiovascular events and healthcare utilization in clinic enrollees versus matched controls. Regulators may also examine whether high out-of-pocket fees align with IRS community-benefit requirements for tax-exempt hospitals.

Evidence quality remains low: the STAT piece is investigative journalism without primary data; supporting observational studies cannot establish causality or rule out selection bias in affluent cohorts.